433 related articles for article (PubMed ID: 24840099)
1. Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer.
Bedi U; Mishra VK; Wasilewski D; Scheel C; Johnsen SA
Oncotarget; 2014 Apr; 5(8):2016-29. PubMed ID: 24840099
[TBL] [Abstract][Full Text] [Related]
2. Aspects of the Epigenetic Regulation of EMT Related to Cancer Metastasis.
Nowak E; Bednarek I
Cells; 2021 Dec; 10(12):. PubMed ID: 34943943
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.
Markopoulos GS; Roupakia E; Marcu KB; Kolettas E
Cells; 2019 Sep; 8(10):. PubMed ID: 31557902
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic control of EMT/MET dynamics: HNF4α impacts DNMT3s through miRs-29.
Cicchini C; de Nonno V; Battistelli C; Cozzolino AM; De Santis Puzzonia M; Ciafrè SA; Brocker C; Gonzalez FJ; Amicone L; Tripodi M
Biochim Biophys Acta; 2015 Aug; 1849(8):919-29. PubMed ID: 26003733
[TBL] [Abstract][Full Text] [Related]
5. Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.
Lee JY; Kong G
Cell Mol Life Sci; 2016 Dec; 73(24):4643-4660. PubMed ID: 27460000
[TBL] [Abstract][Full Text] [Related]
6. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells.
Ke XS; Qu Y; Cheng Y; Li WC; Rotter V; Øyan AM; Kalland KH
BMC Genomics; 2010 Nov; 11():669. PubMed ID: 21108828
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of epithelial-mesenchymal transition during cancer development.
Yoodee S; Thongboonkerd V
Int Rev Cell Mol Biol; 2023; 380():1-61. PubMed ID: 37657856
[TBL] [Abstract][Full Text] [Related]
8. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of epithelial-mesenchymal transition.
Sun L; Fang J
Cell Mol Life Sci; 2016 Dec; 73(23):4493-4515. PubMed ID: 27392607
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy of epigenomic regulatory mechanisms controlling the epithelial to mesenchymal transition during tumor progression.
Mishra VK; Johnsen SA
Cell Tissue Res; 2014 Jun; 356(3):617-30. PubMed ID: 24833164
[TBL] [Abstract][Full Text] [Related]
11. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications.
Serrano-Gomez SJ; Maziveyi M; Alahari SK
Mol Cancer; 2016 Feb; 15():18. PubMed ID: 26905733
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis.
Wang Y; Shang Y
Exp Cell Res; 2013 Jan; 319(2):160-9. PubMed ID: 22935683
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity.
Skrypek N; Goossens S; De Smedt E; Vandamme N; Berx G
Trends Genet; 2017 Dec; 33(12):943-959. PubMed ID: 28919019
[TBL] [Abstract][Full Text] [Related]
14. The role of GRHL2 and epigenetic remodeling in epithelial-mesenchymal plasticity in ovarian cancer cells.
Chung VY; Tan TZ; Ye J; Huang RL; Lai HC; Kappei D; Wollmann H; Guccione E; Huang RY
Commun Biol; 2019; 2():272. PubMed ID: 31372511
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer.
Galle E; Thienpont B; Cappuyns S; Venken T; Busschaert P; Van Haele M; Van Cutsem E; Roskams T; van Pelt J; Verslype C; Dekervel J; Lambrechts D
Clin Epigenetics; 2020 Feb; 12(1):27. PubMed ID: 32059745
[TBL] [Abstract][Full Text] [Related]
16. The epigenetics of epithelial-mesenchymal plasticity in cancer.
Tam WL; Weinberg RA
Nat Med; 2013 Nov; 19(11):1438-49. PubMed ID: 24202396
[TBL] [Abstract][Full Text] [Related]
17. Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT.
Díaz-López A; Díaz-Martín J; Moreno-Bueno G; Cuevas EP; Santos V; Olmeda D; Portillo F; Palacios J; Cano A
Int J Cancer; 2015 Feb; 136(4):E62-73. PubMed ID: 25178837
[TBL] [Abstract][Full Text] [Related]
18. HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.
Ruscetti M; Dadashian EL; Guo W; Quach B; Mulholland DJ; Park JW; Tran LM; Kobayashi N; Bianchi-Frias D; Xing Y; Nelson PS; Wu H
Oncogene; 2016 Jul; 35(29):3781-95. PubMed ID: 26640144
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-to-mesenchymal transition in tumor progression.
Prieto-García E; Díaz-García CV; García-Ruiz I; Agulló-Ortuño MT
Med Oncol; 2017 Jul; 34(7):122. PubMed ID: 28560682
[TBL] [Abstract][Full Text] [Related]
20. EMT is associated with an epigenetic signature of ECM remodeling genes.
Peixoto P; Etcheverry A; Aubry M; Missey A; Lachat C; Perrard J; Hendrick E; Delage-Mourroux R; Mosser J; Borg C; Feugeas JP; Herfs M; Boyer-Guittaut M; Hervouet E
Cell Death Dis; 2019 Feb; 10(3):205. PubMed ID: 30814494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
